Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

Shots:

Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21
BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston Scientific’s global kidney stone management portfolio and will expand its footprints in the EU and Asia
Lumenis’ surgical business includes premier laser systems, fibers and accessories used for urology and otolaryngology procedures

Click here to read full press release/ article | Ref: PRNewswire | Image: Medical Device and Diagnostic Industry